Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment

• Philippe van Wilder,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Research Centre in Health Economics, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Irina Odnoletkova,

  Roles Conceptualization, Funding acquisition, Methodology, Writing – review & editing

  Affiliation Research Centre in Health Economics, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Mehdi Mouline,

  Roles Formal analysis, Writing – review & editing

  Affiliation Research Centre in Health Economics, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Esther de Vries

  Roles Data curation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: e.devries@tilburguniversity.edu

  Affiliations Dept Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands, Laboratory of Medical Microbiology and Immunology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands

  https://orcid.org/0000-0003-4311-3550

  ⨯